Related references
Note: Only part of the references are listed.Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades
Migle Paskeviciute et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2019)
Extending Arms of Insulin Resistance from Diabetes to Alzheimer's Disease: Identification of Potential Therapeutic Targets
Smriti Gupta et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2019)
Niacin induces miR-502-3p expression which impairs insulin sensitivity in human adipocytes
Emilie Montastier et al.
INTERNATIONAL JOURNAL OF OBESITY (2019)
INDUCED PLURIPOTENT STEM CELLS AND THEIR USE IN HUMAN MODELS OF DISEASE AND DEVELOPMENT
Peter Karagiannis et al.
PHYSIOLOGICAL REVIEWS (2019)
Concise Review: Laying the Groundwork for a First-In-Human Study of an Induced Pluripotent Stem Cell-Based Intervention for Spinal Cord Injury
Osahiko Tsuji et al.
STEM CELLS (2019)
Patisiran for the treatment of hereditary transthyretin-mediated amyloidosis
Junyi Yang
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
Arnt Kristen et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2019)
Functional miRNAs in breast cancer drug resistance
Weizi Hu et al.
ONCOTARGETS AND THERAPY (2018)
Current Strategies for Brain Drug Delivery
Xiaowei Dong
THERANOSTICS (2018)
MicroRNA-298 Reverses Multidrug Resistance to Antiepileptic Drugs by Suppressing MDR1/P-gp Expression in vitro
Yangmei Xie et al.
FRONTIERS IN NEUROSCIENCE (2018)
被撤回的出版物: The miR 495-UBE2C-ABCG2/ERCC1 axis reverses cisplatin resistance by downregulating drug resistance genes in cisplatin-resistant non-small cell lung cancer cells (Retracted article. See vol. 63, 2021)
Jiwei Guo et al.
EBIOMEDICINE (2018)
MicroRNAs as Therapeutic Agents: The Future of the Battle Against Cancer
Sumit Biswas
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2018)
Current chemotherapy strategies in malignant pleural mesothelioma
Cornedine Jannette de Gooijer et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2018)
miR-155 in cancer drug resistance and as target for miRNA-based therapeutics
Recep Bayraktar et al.
CANCER AND METASTASIS REVIEWS (2018)
Evaluation of serum extracellular vesicle isolation methods for profiling miRNAs by next-generation sequencing
Dominik Buschmann et al.
JOURNAL OF EXTRACELLULAR VESICLES (2018)
Combination therapy to checkmate Glioblastoma: clinical challenges and advances
Debarati Ghosh et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers
Katrien Van Roosbroeck et al.
CLINICAL CANCER RESEARCH (2017)
Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study
Nico van Zandwijk et al.
LANCET ONCOLOGY (2017)
Cell-to-cell communication: microRNAs as hormones
Recep Bayraktar et al.
MOLECULAR ONCOLOGY (2017)
Levels of microRNA miR-16 and miR-155 are altered in serum of patients with tuberculosis and associate with responses to therapy
Vishal Wagh et al.
TUBERCULOSIS (2017)
Dual targeting of the cancer antioxidant network with 1,4-naphthoquinone fused Gold(I) N-heterocyclic carbene complexes
R. McCall et al.
CHEMICAL SCIENCE (2017)
Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs
Mohammed H. Rashed et al.
ONCOTARGET (2017)
Ubiquitous Release of Exosomal Tumor Suppressor miR-6126 from Ovarian Cancer Cells
Pinar Kanlikilicer et al.
CANCER RESEARCH (2016)
Circulating MicroRNAs: A Next-Generation Clinical Biomarker for Digestive System Cancers
Tsutomu Kawaguchi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Clinical development of TargomiRs, a miRNA mimic-based treatment for patients with recurrent thoracic cancer
Glen Reid et al.
EPIGENOMICS (2016)
Tools for Sequence-Based miRNA Target Prediction: What to Choose?
Angela L. Riffo-Campos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
In vivo delivery of miRNAs for cancer therapy: Challenges and strategies
Yunching Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Preclinical and clinical development of siRNA-based therapeutics
Gulnihal Ozcan et al.
ADVANCED DRUG DELIVERY REVIEWS (2015)
Thinking small: towards microRNA-based therapeutics for anxiety disorders
Karen A. Scott et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Aberrant microRNA expression in peripheral plasma and mononuclear cells as specific blood-based biomarkers in schizophrenia patients
Xin-yang Sun et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2015)
Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor
Tarun Garg et al.
JOURNAL OF DRUG TARGETING (2015)
The Landscape of long noncoding RNA classification
Georges St Laurent et al.
TRENDS IN GENETICS (2015)
Circulating microRNAs are promising novel biomarkers for drug-resistant epilepsy
Jun Wang et al.
SCIENTIFIC REPORTS (2015)
Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome
Bhumsoo Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2015)
Conventional and novel diagnostic biomarkers of acute myocardial infarction: a promising role for circulating microRNAs
Rina Recchioni et al.
BIOMARKERS (2013)
Treatment of HCV Infection by Targeting MicroRNA
Harry L. A. Janssen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Alterations of Serum Levels of BDNF-Related miRNAs in Patients with Depression
You-Jie Li et al.
PLOS ONE (2013)
The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes
Alessia Gallo et al.
PLOS ONE (2012)
Computational analysis of noncoding RNAs
Stefan Washietl et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2012)
Circulating microRNAs: promising candidates serving as novel biomarkers of acute hepatitis
Natalia Elfimova et al.
FRONTIERS IN PHYSIOLOGY (2012)
Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
Jannet Kocerha et al.
BMC GENOMICS (2011)
Circulating MicroRNAs are Promising Novel Biomarkers of Acute Myocardial Infarction
Rongrong Wang et al.
INTERNAL MEDICINE (2011)
Development of biomarkers for Huntington's disease
David W. Weir et al.
LANCET NEUROLOGY (2011)
The productivity crisis in pharmaceutical R&D
Fabio Pammolli et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Assessing the Utility of Thermodynamic Features for microRNA Target Prediction under Relaxed Seed and No Conservation Requirements
Parawee Lekprasert et al.
PLOS ONE (2011)
The MicroRNA Spectrum in 12 Body Fluids
Jessica A. Weber et al.
CLINICAL CHEMISTRY (2010)
Therapeutic Silencing of MicroRNA-122 in Primates with Chronic Hepatitis C Virus Infection
Robert E. Lanford et al.
SCIENCE (2010)
MicroRNAs: Target Recognition and Regulatory Functions
David P. Bartel
CELL (2009)
Network pharmacology: the next paradigm in drug discovery
Andrew L. Hopkins
NATURE CHEMICAL BIOLOGY (2008)
The Inhibition of the Highly Expressed Mir-221 and Mir-222 Impairs the Growth of Prostate Carcinoma Xenografts in Mice
Neri Mercatelli et al.
PLOS ONE (2008)
ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal
Cheol-Hee Choi
CANCER CELL INTERNATIONAL (2005)
Finishing the euchromatic sequence of the human genome
FS Collins et al.
NATURE (2004)
Initial sequencing and analysis of the human genome
ES Lander et al.
NATURE (2001)
Share Paper
